AR42, a novel histone deacetylase inhibitor, as a potential therapy for vestibular schwannomas and meningiomasMatthew L. Bush, Abraham Jacob|Neuro-Oncology|2011Cited by 80
Older Individuals Meeting Medicare Cochlear Implant Candidacy Criteria in Noise but Not in Quiet: Are These Patients Improved by Surgery?Jordan A. Mudery, Abraham Jacob, Ross H. Francis et al.|Otology & Neurotology|2016Cited by 34